Nanosphere, Inc.
E166836
Nanosphere, Inc. was a biotechnology company specializing in nanoparticle-based molecular diagnostic tests for detecting genetic and infectious diseases.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Nanosphere, Inc. canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T1468820 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Nanosphere, Inc. Context triple: [Chad Mirkin, founded, Nanosphere, Inc.]
-
A.
Microsystems Technology Laboratories
Microsystems Technology Laboratories is a leading MIT research facility focused on micro- and nano-scale engineering, including microelectronics, MEMS, and related technologies.
-
B.
Arthur D. Little, Inc.
Arthur D. Little, Inc. is a pioneering global management consulting firm known for its work in technology, innovation, and strategy across a wide range of industries.
-
C.
Goodrich Corporation
Goodrich Corporation was a major American aerospace and defense company known for manufacturing aircraft systems and components before its acquisition by United Technologies Corporation.
-
D.
Heptares Therapeutics
Heptares Therapeutics is a biopharmaceutical company specializing in the discovery and development of medicines targeting G protein-coupled receptors (GPCRs) using its proprietary structure-based drug design technologies.
-
E.
BioQuarter
BioQuarter is a major biomedical research and innovation campus in Edinburgh that brings together university researchers, healthcare facilities, and life science companies.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Nanosphere, Inc. Target entity description: Nanosphere, Inc. was a biotechnology company specializing in nanoparticle-based molecular diagnostic tests for detecting genetic and infectious diseases.
-
A.
Microsystems Technology Laboratories
Microsystems Technology Laboratories is a leading MIT research facility focused on micro- and nano-scale engineering, including microelectronics, MEMS, and related technologies.
-
B.
Arthur D. Little, Inc.
Arthur D. Little, Inc. is a pioneering global management consulting firm known for its work in technology, innovation, and strategy across a wide range of industries.
-
C.
Goodrich Corporation
Goodrich Corporation was a major American aerospace and defense company known for manufacturing aircraft systems and components before its acquisition by United Technologies Corporation.
-
D.
Heptares Therapeutics
Heptares Therapeutics is a biopharmaceutical company specializing in the discovery and development of medicines targeting G protein-coupled receptors (GPCRs) using its proprietary structure-based drug design technologies.
-
E.
BioQuarter
BioQuarter is a major biomedical research and innovation campus in Edinburgh that brings together university researchers, healthcare facilities, and life science companies.
- F. None of above. chosen
Statements (25)
| Predicate | Object |
|---|---|
| instanceOf |
biotechnology company
ⓘ
medical diagnostics company ⓘ |
| businessModel | commercialization of diagnostic platforms ⓘ |
| country |
United States
ⓘ
linked to:
United States of America
|
| focus |
clinical microbiology testing
ⓘ
genetic disease testing ⓘ infectious disease testing ⓘ |
| goal |
improve accuracy of diagnostic testing
ⓘ
improve sensitivity of diagnostic testing ⓘ improve speed of diagnostic testing ⓘ |
| headquartersLocation |
United States
ⓘ
linked to:
United States of America
|
| industry |
biotechnology
ⓘ
molecular diagnostics ⓘ |
| productType | in vitro diagnostic tests ⓘ |
| sector |
healthcare
ⓘ
life sciences ⓘ |
| specialization |
diagnostic tests for genetic diseases
ⓘ
diagnostic tests for infectious diseases ⓘ nanoparticle-based molecular diagnostic tests ⓘ |
| status | defunct ⓘ |
| technology |
molecular diagnostics platforms
ⓘ
nanoparticle-based detection ⓘ |
| usedFor |
clinical laboratory diagnostics
ⓘ
detection of genetic markers ⓘ detection of infectious agents ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Nanosphere, Inc. Description of subject: Nanosphere, Inc. was a biotechnology company specializing in nanoparticle-based molecular diagnostic tests for detecting genetic and infectious diseases.
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.